Flock, smart-money disclosures made readable

Flock, smart-money disclosures made readable

Show all 39 disclosures

DISCLOSEDQuarterly
Soros Fund Management
Abbott Laboratories · NASDAQ
44,750 sh · $4.1M
Filed 30 Jun 2026SEC 13Fview source
DISCLOSEDQuarterly
Gardner Russo & Quinn
Abbott Laboratories · NASDAQ
11,510 sh · $1.0M
Filed 30 Jun 2026SEC 13Fview source
DISCLOSEDQuarterly
Dodge & Cox
Abbott Laboratories · NASDAQ
17,324 sh · $1.6M
Filed 30 Jun 2026SEC 13Fview source
DISCLOSEDStale
Polen Capital Management
Abbott Laboratories · NASDAQ
15,081 sh · $1.5M
Filed 31 Mar 2026SEC 13Fview source
DISCLOSEDStale
Two Sigma Investments
Abbott Laboratories · NASDAQ
6,441,328 sh · $661.3M
Filed 31 Mar 2026SEC 13Fview source
DISCLOSEDStale
Renaissance Technologies
Abbott Laboratories · NASDAQ
1,238,666 sh · $127.2M
Filed 31 Mar 2026SEC 13Fview source
DISCLOSEDStale
Gardner Russo & Quinn
Abbott Laboratories · NASDAQ
11,510 sh · $1.2M
Filed 31 Mar 2026SEC 13Fview source
DISCLOSEDStale
Dodge & Cox
Abbott Laboratories · NASDAQ
17,324 sh · $1.8M
Filed 31 Mar 2026SEC 13Fview source
DISCLOSEDStale
BlackRock
Abbott Laboratories · NASDAQ
145,793,958 sh · $14.97B
Filed 31 Mar 2026SEC 13Fview source
DISCLOSEDStale
Bridgewater Associates
Abbott Laboratories · NASDAQ
117,051 sh · $12.0M
Filed 31 Mar 2026SEC 13Fview source
DISCLOSEDStale
Soros Fund Management
Abbott Laboratories · NASDAQ
44,750 sh · $4.6M
Filed 31 Mar 2026SEC 13Fview source
DISCLOSEDStale
BlackRock
Abbott Laboratories · NASDAQ
146,908,768 sh · $18.41B
Filed 31 Dec 2025SEC 13Fview source
DISCLOSEDStale
Dodge & Cox
Abbott Laboratories · NASDAQ
17,324 sh · $2.2M
Filed 31 Dec 2025SEC 13Fview source
DISCLOSEDStale
Gardner Russo & Quinn
Abbott Laboratories · NASDAQ
11,510 sh · $1.4M
Filed 31 Dec 2025SEC 13Fview source
DISCLOSEDStale
Polen Capital Management
Abbott Laboratories · NASDAQ
3,962,230 sh · $496.4M
Filed 31 Dec 2025SEC 13Fview source
DISCLOSEDStale
Dodge & Cox
Abbott Laboratories · NASDAQ
17,324 sh · $2.3M
Filed 30 Sept 2025SEC 13Fview source
DISCLOSEDStale
Polen Capital Management
Abbott Laboratories · NASDAQ
7,420,604 sh · $993.9M
Filed 30 Sept 2025SEC 13Fview source
DISCLOSEDStale
Gardner Russo & Quinn
Abbott Laboratories · NASDAQ
11,510 sh · $1.5M
Filed 30 Sept 2025SEC 13Fview source
DISCLOSEDStale
BlackRock
Abbott Laboratories · NASDAQ
141,559,956 sh · $18.96B
Filed 30 Sept 2025SEC 13Fview source
DISCLOSEDStale
Gardner Russo & Quinn
Abbott Laboratories · NASDAQ
11,510 sh · $1.6M
Filed 30 Jun 2025SEC 13Fview source
DISCLOSEDStale
Polen Capital Management
Abbott Laboratories · NASDAQ
10,669,498 sh · $1.45B
Filed 30 Jun 2025SEC 13Fview source
DISCLOSEDStale
Dodge & Cox
Abbott Laboratories · NASDAQ
17,324 sh · $2.4M
Filed 30 Jun 2025SEC 13Fview source
DISCLOSEDStale
BlackRock
Abbott Laboratories · NASDAQ
141,287,026 sh · $19.22B
Filed 30 Jun 2025SEC 13Fview source
DISCLOSEDStale
BlackRock
Abbott Laboratories · NASDAQ
136,977,160 sh · $18.17B
Filed 31 Mar 2025SEC 13Fview source
DISCLOSEDStale
BlackRock
Abbott Laboratories · NASDAQ
136,534,575 sh · $15.44B
Filed 31 Dec 2024SEC 13Fview source
DISCLOSEDStale
BlackRock
Abbott Laboratories · NASDAQ
131,027,791 sh · $14.94B
Filed 30 Sept 2024SEC 13Fview source
DISCLOSEDStale
BlackRock
Abbott Laboratories · NASDAQ
131,129,688 sh · $13.63B
Filed 30 Jun 2024SEC 13Fview source
DISCLOSEDStale
BlackRock
Abbott Laboratories · NASDAQ
133,576,228 sh · $15.18B
Filed 31 Mar 2024SEC 13Fview source
DISCLOSEDStale
BlackRock
Abbott Laboratories · NASDAQ
134,064,516 sh · $14.76B
Filed 31 Dec 2023SEC 13Fview source